Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy

Patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are prone to present with antibody production deficits associated with recurrent or severe bacterial infections that might benefit from human immunoglobulin (Ig) (IVIg/SCIg) replacement therapy. However, the original IVIg tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Ramón, Silvia, Dhalla, Fatima, Chapel, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993076/
https://www.ncbi.nlm.nih.gov/pubmed/27597852
http://dx.doi.org/10.3389/fimmu.2016.00317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993076/
https://www.ncbi.nlm.nih.gov/pubmed/27597852
http://dx.doi.org/10.3389/fimmu.2016.00317

Ejemplares similares